Esophageal Cancer Trial Results
Can Aspirin Reduce Cancer Risk and Mortality?
(Posted: 03/30/2011) - A meta-analysis of eight clinical trials involving regular aspirin use showed a substantial reduction in mortality for a number of different cancers.

Radiofrequency Ablation Effective Against Barrett Esophagus
(Posted: 07/23/2009) - In a randomized phase II trial, radiofrequency ablation led to high rates of eradication of the cell abnormalities associated with Barrett esophagus, according to the May 28, 2009, New England Journal of Medicine.

Radiation and Chemo Before Esophageal Cancer Surgery Improves Survival
(Posted: 08/21/2007) - Preoperative (neoadjuvant) use of combination chemoradiotherapy helped patients with localized esophageal cancer to live longer, according to the March 2007 Lancet Oncology.

Patients With Esophageal Cancer May Be Able to Avoid Surgery
(Posted: 04/16/2007) - Patients with esophageal cancer lived just as long after receiving chemoradiation therapy alone as did those whose chemoradiation therapy was followed by surgery, according to the April 1, 2007, Journal of Clinical Oncology.

New Chemotherapy Regimen Extends Survival for Patients with Resectable Gastric Cancer
(Posted: 07/12/2006) - When it comes to chemotherapy for locally invasive gastric cancer, results from an international clinical trial published in the July 6, 2006, issue of the New England Journal of Medicine suggest that timing can make all the difference.

(Posted: 03/30/2011) - A meta-analysis of eight clinical trials involving regular aspirin use showed a substantial reduction in mortality for a number of different cancers.
Radiofrequency Ablation Effective Against Barrett Esophagus
(Posted: 07/23/2009) - In a randomized phase II trial, radiofrequency ablation led to high rates of eradication of the cell abnormalities associated with Barrett esophagus, according to the May 28, 2009, New England Journal of Medicine.
Radiation and Chemo Before Esophageal Cancer Surgery Improves Survival
(Posted: 08/21/2007) - Preoperative (neoadjuvant) use of combination chemoradiotherapy helped patients with localized esophageal cancer to live longer, according to the March 2007 Lancet Oncology.
Patients With Esophageal Cancer May Be Able to Avoid Surgery
(Posted: 04/16/2007) - Patients with esophageal cancer lived just as long after receiving chemoradiation therapy alone as did those whose chemoradiation therapy was followed by surgery, according to the April 1, 2007, Journal of Clinical Oncology.
New Chemotherapy Regimen Extends Survival for Patients with Resectable Gastric Cancer
(Posted: 07/12/2006) - When it comes to chemotherapy for locally invasive gastric cancer, results from an international clinical trial published in the July 6, 2006, issue of the New England Journal of Medicine suggest that timing can make all the difference.
Table of Links | |
| 1 | http://www.cancer.gov/clinicaltrials/search |
| 2 | http://www.cancer.gov/cancertopics/types/esophageal |
